PPAR-γ is a central regulator of insulin sensitization and glucose lowering in adipose tissues and has been suggested as a therapeutic target for DM treatment by drugs such as thiazolidinediones [67, 68]. The gene discussed is PPARG; the disease is diabetes mellitus.